Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber(National Institutes of Health), Alan Sher(National Institute of Allergy and Infectious Diseases)
Cited by 776
Related Papers
Effector Cells of Both Nonhemopoietic and Hemopoietic Origin Are Required for Interferon (IFN)-γ– and Tumor Necrosis Factor (TNF)-α–dependent Host Resistance to the Intracellular Pathogen, <i>Toxoplasma gondii </i>
|The Journal of Experimental Medicine|1999|244
Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection
|Mucosal Immunology|2020|33